Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 2)

Biliary Tract Neoplasms (Phase 2)

Breast Neoplasms (Phase 3)

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Renal Cell (Phase 3)

Carcinoma, Squamous Cell (Phase 3)

Carcinoma, Transitional Cell (Phase 3)

Cholangiocarcinoma (Phase 2)

Colorectal Neoplasms (Phase 2)

Disease Progression (Phase 2)

Esophageal Neoplasms (Phase 2)

Esophageal Squamous Cell Carcinoma (Phase 3)

Hypercholesterolemia (Phase 1)

Hyperlipidemias (Phase 2)

Hyperlipoproteinemias (Phase 2)

Hypopharyngeal Neoplasms (Phase 2)

Infections (Phase 3)

Kidney Neoplasms (Phase 1)

Liver Neoplasms (Phase 2)

Lung Neoplasms (Phase 3)

Lymphoma (Phase 1)

Melanoma (Phase 3)

Nasopharyngeal Carcinoma (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Squamous Cell (Phase 3)

Neuroendocrine Tumors (Phase 1)

Small Cell Lung Carcinoma (Phase 3)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Stomach Neoplasms (Phase 2)

Triple Negative Breast Neoplasms (Phase 3)

Urologic Neoplasms (Phase 1)